Nuclear Medicine AtlasInteractive atlas

Ventilation Agents (Technegas, Aerosols, Xenon)⁹⁹ᵐTc-Technegas / DTPA aerosol · ¹³³Xe

The ventilation half of the V/Q study

Evidence B#pulmonary#ventilation#VQUpdated 2026-07-27 · Physician-reviewed
High-yield mode — key points, high-yield facts, tables & quizzes only. Toggle off for full text.

Quick Answer

Ventilation agents map regional airflow for the "V" of the V/Q scan, compared against Tc-99m-MAA perfusion. Tc-99m-Technegas (ultrafine carbon-encapsulated technetium) behaves almost like a gas, distributes peripherally and uniformly, and is ideal for SPECT V/Q; Tc-99m-DTPA aerosol is widely available but shows central airway "hot-spot" deposition in airflow obstruction; Xe-133 gas uniquely allows washin/washout (air-trapping) assessment but at lower resolution with workflow constraints. The governing rule: acquire V and Q with matched technique and positioning.

Mechanism

  • Technegas: technetium condensed onto ultrafine carbon nanoparticles in an argon-filled generator; the particles are small enough to behave as a "pseudogas," depositing in the distal airspaces by diffusion — near-uniform peripheral distribution.
  • Tc-99m-DTPA aerosol: a nebulized liquid aerosol; larger, variably sized droplets deposit more centrally, especially where turbulent flow occurs in obstruction.
  • Xe-133 / Kr-81m gases: true gases; xenon supports dynamic washin (equilibrium) and washout phases that reveal air trapping; Kr-81m (from a Rb-81 generator) allows continuous imaging but is availability-limited.

Physics & Agents

Agent Nature Half-life / photon Notes
Tc-99m-Technegas Carbon nanoparticle "pseudogas" 6 h / 140 keV Peripheral, uniform; ideal for SPECT V/Q
Tc-99m-DTPA aerosol Nebulized aerosol 6 h / 140 keV Available; central "hot spots" in COPD
Xe-133 Radioactive gas 5.2 d / 81 keV Washin/washout for air trapping; lower resolution; imaged before perfusion
Kr-81m Generator gas 13 s / 190 keV Continuous imaging; limited availability

Clinical Indications

  • Ventilation half of the V/Q scan for suspected pulmonary embolism (paired with MAA perfusion; mismatch = PE).
  • Air-trapping evaluation (Xe-133 washout) in obstructive disease.
  • Quantitative regional ventilation (e.g., pre-lung-resection or lung-volume-reduction planning) — Technegas SPECT.

Preparation & Protocol

  • Technegas: a few tidal breaths inhaled; then image (planar or SPECT), followed by MAA perfusion.
  • Xe-133: imaged in a single posterior projection first (before perfusion), through washin → equilibrium → washout, because its lower energy (81 keV) would be swamped by the subsequent Tc-99m perfusion dose.
  • Low-energy collimator for Tc/Xe photons; ensure matched positioning between V and Q.

Interpretation Highlights

  • V/Q mismatch (perfusion defect with preserved ventilation) is the hallmark of PE; matched defects favor parenchymal disease.
  • Central aerosol clumping in COPD can mimic or obscure defects — recognize the artifact.
  • Xe-133 washout retention indicates air trapping (obstruction).

Reporting Checklist

  • State the ventilation agent and technique (planar vs SPECT), and confirm matched V/Q positioning.
  • Describe mismatch vs matched defects for the PE question.
  • Note aerosol central deposition or xenon air-trapping findings.

Common Pitfalls

  • Central aerosol clumping in obstruction mimicking/obscuring defects.
  • Comparing V and Q acquired with mismatched technique/positioning.
  • Imaging Xe-133 after the Tc-99m perfusion dose (its low-energy photons are overwhelmed) — xenon ventilation must come first.

Board Pearls

Ventilation agents map regional airflow for the "V" of the V/Q study against Tc-99m-MAA perfusion. Technegas (ultrafine carbon pseudogas) distributes peripherally and uniformly — ideal for SPECT V/Q; Tc-99m-DTPA aerosol is widely available but shows central "hot-spot" deposition in obstruction; Xe-133 gas uniquely adds washin/washout air-trapping assessment at lower resolution.

A V/Q mismatch (perfusion defect, preserved ventilation) is the hallmark of PE; matched defects favor parenchymal disease. Always compare V and Q with matched technique and positioning — a mismatch of technique masquerades as a mismatch of physiology.

Xe-133 must be imaged before perfusion (single posterior view; washin → equilibrium → washout) because its 81-keV photons would be swamped by the subsequent 140-keV Tc-99m dose. Kr-81m (13-s, generator) allows continuous same-session imaging but is availability-limited. Technegas SPECT enables quantitative regional ventilation for surgical planning.

  • Perfusion agent: Tc-99m-MAA; protocol: V/Q scan for PE.

Figure / Diagram Suggestions

  • A particle-size deposition schematic (Technegas peripheral vs aerosol central).
  • A Xe-133 washin/washout time-course showing air trapping.
  • A V/Q mismatch vs matched teaching pair.

Self-Check

Q1. Why does Tc-99m-DTPA aerosol show central "hot spots" in COPD while Technegas does not?

Answer: Aerosol droplets are larger and deposit centrally in turbulent obstructed airways; Technegas's ultrafine pseudogas particles reach the periphery uniformly.

Q2. Why must Xe-133 ventilation be imaged before the Tc-99m perfusion scan?

Answer: Xe-133's lower-energy 81-keV photons would be overwhelmed by the subsequent 140-keV Tc-99m perfusion dose.

Q3. What ventilation finding uniquely indicates air trapping, and which agent shows it?

Answer: Washout retention of Xe-133 during the washout phase indicates air trapping (obstruction).

Q4. Which ventilation agent is best suited to SPECT V/Q and quantitative regional ventilation, and why?

Answer: Technegas — its uniform peripheral "pseudogas" distribution supports tomographic and quantitative imaging.

Evidence & sources

BEANM/SNMMI V/Q guidelines — Technegas, aerosol, and xenon ventilation agents; SPECT V/Q.
Cite this page. Nuclear Medicine Atlas. “Ventilation Agents (Technegas, Aerosols, Xenon).” v1.76, 2026-10-25. Permalink: https://nuc.med/ventilation-agents/ Report an issue
Nuclear Medicine Atlas · v1.76 · built 2026-10-25Terms · Privacy · Disclaimer